HomeCompareCURE vs SPHD

CURE vs SPHD: Dividend Comparison 2026

CURE yields 1.30% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPHD wins by $5.0K in total portfolio value
10 years
CURE
CURE
● Live price
1.30%
Share price
$91.57
Annual div
$1.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$141.38
Full CURE calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — CURE vs SPHD

📍 SPHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCURESPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CURE + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CURE pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CURE
Annual income on $10K today (after 15% tax)
$110.46/yr
After 10yr DRIP, annual income (after tax)
$120.17/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, SPHD beats the other by $365.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CURE + SPHD for your $10,000?

CURE: 50%SPHD: 50%
100% SPHD50/50100% CURE
Portfolio after 10yr
$24.0K
Annual income
$356.35/yr
Blended yield
1.48%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CURE buys
0
SPHD buys
0
No recent congressional trades found for CURE or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCURESPHD
Forward yield1.30%4.33%
Annual dividend / share$1.19$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$21.5K$26.5K
Annual income after 10y$141.38$571.32
Total dividends collected$1.4K$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CURE vs SPHD ($10,000, DRIP)

YearCURE PortfolioCURE Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$10,830$129.96$11,133$432.85$303.00SPHD
2$11,720$131.53$12,363$450.36$643.00SPHD
3$12,673$133.03$13,695$467.39$1.0KSPHD
4$13,695$134.44$15,138$483.90$1.4KSPHD
5$14,789$135.77$16,697$499.88$1.9KSPHD
6$15,961$137.03$18,382$515.31$2.4KSPHD
7$17,217$138.22$20,198$530.17$3.0KSPHD
8$18,561$139.33$22,157$544.46$3.6KSPHD
9$20,001$140.39$24,266$558.18$4.3KSPHD
10$21,542$141.38$26,536$571.32$5.0KSPHD

CURE vs SPHD: Complete Analysis 2026

CUREStock

The Direxion Daily Healthcare Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. There is no guarantee the fund will achieve its stated investment objectives.

Full CURE Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this CURE vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CURE vs SCHDCURE vs JEPICURE vs OCURE vs KOCURE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.